2024-03-28T14:17:45Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_33535700F126
2024-03-23T02:09:02Z
openaire
documents
urnserval
serval:BIB_33535700F126
Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort.
10.1186/s12879-019-4454-9
000500567400001
31601174
Surial
B.
author
Cavassini
M.
author
Calmy
A.
author
Fehr
J.
author
Stöckle
M.
author
Bernasconi
E.
author
Roth
B.
author
Fux
C.A.
author
Kovari
H.
author
Furrer
H.
author
Rauch
A.
author
Wandeler
G.
author
Swiss HIV Cohort Study
contributor
Anagnostopoulos
A.
contributor
Battegay
M.
contributor
Bernasconi
E.
contributor
Böni
J.
contributor
Braun
D.L.
contributor
Bucher
H.C.
contributor
Calmy
A.
contributor
Cavassini
M.
contributor
Ciuffi
A.
contributor
Dollenmaier
G.
contributor
Egger
M.
contributor
Elzi
L.
contributor
Fehr
J.
contributor
Fellay
J.
contributor
Furrer
H.
contributor
Fux
C.A.
contributor
Günthard
H.F.
contributor
Haerry
D.
contributor
Hasse
B.
contributor
Hirsch
H.H.
contributor
Hoffmann
M.
contributor
Hösli
I.
contributor
Huber
M.
contributor
Kahlert
C.R.
contributor
Kaiser
L.
contributor
Keiser
O.
contributor
Klimkait
T.
contributor
Kouyos
R.D.
contributor
Kovari
H.
contributor
Ledergerber
B.
contributor
Martinetti
G.
contributor
Martinez de Tejada
B.
contributor
Marzolini
C.
contributor
Metzner
K.J.
contributor
Müller
N.
contributor
Nicca
D.
contributor
Paioni
P.
contributor
Pantaleo
G.
contributor
Perreau
M.
contributor
Rauch
A.
contributor
Rudin
C.
contributor
Scherrer
A.U.
contributor
Schmid
P.
contributor
Speck
R.
contributor
Stöckle
M.
contributor
Tarr
P.
contributor
Trkola
A.
contributor
Vernazza
P.
contributor
Wandeler
G.
contributor
Weber
R.
contributor
Yerly
S.
contributor
article
2019-10-10
BMC infectious diseases
1471-2334
1471-2334
journal
19
1
834
Adenine/analogs & derivatives
Adenine/therapeutic use
Adult
Anti-HIV Agents/therapeutic use
CD4 Lymphocyte Count
Cohort Studies
Drug Interactions
Female
HIV Infections/complications
HIV Infections/drug therapy
Hepatitis C, Chronic/complications
Hepatitis C, Chronic/pathology
Humans
Male
Middle Aged
Risk Factors
Switzerland
Tenofovir/adverse effects
Tenofovir/therapeutic use
Antiretroviral therapy
Switch
Tenofovir alafenamide
Tenofovir disoproxil fumarate
Toxicity
eng
60_published
true
peer-reviewed
Publication types: Journal Article
Publication Status: epublish
https://serval.unil.ch/notice/serval:BIB_33535700F126
https://serval.unil.ch/resource/serval:BIB_33535700F126.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_33535700F1261
Creative Commons : Attribution 4.0 International